News
Purple Biotech showcased its CAPTN-3 tri-specific antibody platform's preclinical data at EACR 2025, demonstrating significant anti-tumor activity.
Fraction, PDF, Vitamin C, Anticancer, Pancreatic Cancer, Cervical Cancer, Small-Cell Lung Cancer Share and Cite: Konno, S. , Penunuri, A. , Wong, J. , Fullerton, S. and Choudhury, M. (2025) Anticancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback